Attacking the source: Anti-PDX-1 responses in type 1 diabetes

Laboratory Investigation

Volumn 90, Issue 1, 2010, Pages 6-8

  Luzardo, Yaima ^a   Mathews, Clayton Elwood ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; HOMEODOMAIN PROTEIN; INSULIN ANTIBODY; TRANSCRIPTION FACTOR PDX 1;

ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CELL REGENERATION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; STEM CELL; T LYMPHOCYTE;

EID: 73349092413     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.121     Document Type: Review

References (31)

1. Eisenbarth GS, Jeffrey J. The natural history of type 1A diabetes. Arquivos brasileiros de endocrinologia e metabologia 2008;52:146-155.
2. Pietropaolo M, Yu S, Libman IM, et al. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes 2005;6:184-192.
3. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-933.
4. Wang J, Miao D, Babu S, et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 2007;92:88-92.
5. Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PloS One 2008;3:e2435.
6. Lieberman SM, Evans AM, Han B, et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA 2003;100:8384-8388.
7. Lieberman SM, Takaki T, Han B, et al. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J Immunol 2004;173:6727-6734.
8. Jarchum I, Nichol L, Trucco M, et al. Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol (Orlando, Fla) 2008;127:359-365.
9. Takaki T, Marron MP, Mathews CE, et al. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 2006;176:3257-3265.
10. Li S-W, Koya V, Li Y, et al. Pancreatic duodenal homeobox 1 protein is a novel b-cell-specific autoantigen for type 1 diabetes. Lab Invest 2009;90:31-39 (this issue).
11. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007;104:17040-17045.
12. Abiru N, Yu L, Miao D, et al. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J Autoimmun 2001;17:1-6.
13. Guz Y, Montminy MR, Stein R, et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 1995;121:11-18.
14. Ahlgren U, Jonsson J, Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 1996;122:1409-1416.
15. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996;122:983-995.
16. Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997;15:106-110.
17. Gannon M, Ables ET, Crawford L, et al. pdx-1 function is specifically required in embryonic beta cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis. Dev Biol 2008;314: 406-417.
18. Ahlgren U, Jonsson J, Jonsson L, et al. beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998;12:1763-1768.
19. Kulkarni RN, Jhala US, Winnay JN, et al. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 2004;114:828-836.
20. Bottino R, Criscimanna A, Casu A, et al. Recovery of endogenous beta-cell function in nonhuman primates after chemical diabetes induction and islet transplantation. Diabetes 2009;58:442-447.
21. Kritzik MR, Jones E, Chen Z, et al. PDX-1 and Msx-2 expression in the regenerating and developing pancreas. J Endocrinol 1999;163:523-530.
22. Liu T, Wang CY, Gou SM, et al. PDX-1 expression and proliferation of duct epithelial cells after partial pancreatectomy in rats. Hepatobiliary Pancreat Dis Int 2007;6:424-429.
23. Peshavaria M, Larmie BL, Lausier J, et al. Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 2006;55:3289-3298.
24. Takeshita F, Kodama M, Yamamoto H, et al. Streptozotocin-induced partial beta cell depletion in nude mice without hyperglycaemia induces pancreatic morphogenesis in transplanted embryonic stem cells. Diabetologia 2006;49:2948-2958.
25. Tiemann K, Panienka R, Kloppel G. Expression of transcription factors and precursor cell markers during regeneration of beta cells in pancreata of rats treated with streptozotocin. Virchows Arch 2007;450:261-266.
26. Wang ZV, Mu J, Schraw TD, et al. PANIC-ATTAC: a mouse model for inducible and reversible beta-cell ablation. Diabetes 2008;57:2137-2148.
27. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007;117:2553-2561.
28. Sherry NA, Kushner JA, Glandt M, et al. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 2006;55: 3238-3245.
29. Sreenan S, Pick AJ, Levisetti M, et al. Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 1999;48:989-996.
30. Sherry NA, Chen W, Kushner JA, et al. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Endocrinology 2007;148: 5136-5144.
31. Harmon JS, Gleason CE, Tanaka Y, et al. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 1999;48:1995-2000.